home / stock / anip / anip news


ANIP News and Press, ANI Pharmaceuticals Inc. From 06/15/19

Stock Information

Company Name: ANI Pharmaceuticals Inc.
Stock Symbol: ANIP
Market: NASDAQ
Website: anipharmaceuticals.com

Menu

ANIP ANIP Quote ANIP Short ANIP News ANIP Articles ANIP Message Board
Get ANIP Alerts

News, Short Squeeze, Breakout and More Instantly...

ANIP - Stocks To Watch: Spotlight On FOMC, Slack And Paris Air Show

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , iTunes...

ANIP - ANI Pharmaceuticals to Present at Raymond James Life Sciences and MedTech Conference

BAUDETTE, Minn. , June 12, 2019 /PRNewswire/ -- ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) will present on June 18, 2019 at Raymond James' Life Sciences and MedTech Conference in New York City . Arthur Przybyl , President and CEO and Stephen Carey , Vice President and CFO, will present...

ANIP - Teva down 8% premarket after 60 Minutes piece on alleged price fixing

Teva Pharmaceutical Industries (NYSE: TEVA ) slumps  8%  premarket on light volume as investors react to its role in alleged price fixing by generic drug firms. Last night, the investigative journalism show 60 Minutes aired a piece on the issue that named the company as one of th...

ANIP - Citi bullish on managed care players in premarket analyst action

Anthem (NYSE: ANTM ), Centene (NYSE: CNC ) and UnitedHealth Group (NYSE: UNH ) upgraded to Buy at Citigroup. CNC and UNH are both up  1%  premarket. More news on: Anthem, Inc., Centene Corporation, UnitedHealth Group Incorporated, Healthcare stocks news, Read more ...

ANIP - ANI Pharmaceuticals Inc. (ANIP) CEO Arthur Przybyl on Q1 2019 Results - Earnings Call Transcript

ANI Pharmaceuticals Inc. (ANIP) Q1 2019 Earnings Conference Call May 09, 2019 10:30 AM ET Company Participants Arthur Przybyl - President and Chief Executive Officer Stephen Carey - Chief Financial Officer Conference Call Participants Lucas Lee - Raymond James Dewey Steadma...

ANIP - ANI Pharmaceuticals beats by $0.25, beats on revenue

ANI Pharmaceuticals (NASDAQ: ANIP ): Q1 Non-GAAP EPS of $1.30 beats by $0.25 ; GAAP EPS of $0.04 misses by $0.24 . More news on: ANI Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

ANIP - ANI Pharmaceuticals Reports First Quarter 2019 Results and Reaffirms Guidance

BAUDETTE, Minn. , May 9, 2019 /PRNewswire/ -- For the first quarter 2019: Net revenues of $52.9 million , an increase of 14% versus 2018 GAAP net income of $0.4 million and diluted GAAP earnings per share of $0.04 Record adjusted non-GAAP EBITDA of $22.3 million ...

ANIP - ANI Pharmaceuticals Schedules Conference Call to Discuss First Quarter 2019 Financial Results

BAUDETTE, Minn. , May 2, 2019 /PRNewswire/ -- ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) announced today that the Company plans to release its first quarter 2019 financial results on Thursday, May 9, 2019 , before the opening of the U.S. financial markets. The earnings press release will b...

ANIP - ANI Pharmaceuticals Expands Injectable Portfolio with Distribution Agreement for FDA Approved Injectable Product

BAUDETTE, Minn. , April 15, 2019 /PRNewswire/ -- ANI Pharmaceuticals, Inc. ("ANI" or the "Company") (Nasdaq: ANIP) today announced that it has entered into a Distribution Agreement with a U.S. based injectable manufacturer to commercialize a unique specialty injectable product. ...

ANIP - PE firms eyeing Perrigo pharma business

Private equity shops Apollo Global Management and CVC Capital Partners are apparently bidding  for Perrigo's ( PRGO +2.6% ) generic pharmaceuticals unit according to informed sources who add that the business could fetch more than $2.5B. More news on: Perrigo Company plc, Akorn, In...

Previous 10 Next 10